Semaglutide 5mg
Size: 5mg | 99% Purity
nM.Wt: 4113.58
nFormula: C187H291N45O59
nSolubility: H2O
nPurity: >99%
nStorage: -20°C / 3 years
nHalf life: Not established
nCAS No.: 910463-68-2
| Available sizes | 0.05kg |
|---|---|
| Purity (HPLC) | >99% |
| Molecular weight | 4113.58 g/mol |
| Molecular formula | C187H291N45O59 |
| CAS number | 910463-68-2 |
| Synonyms | Ozempic Active Compound, Wegovy Active Compound, NNC9204-0294, OG217SC |
| Solubility | H2O |
| Storage | '-20°C / 3 years |
| Half-life | Not established |
Peptide sequence
His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-NH2
Research reference: View mechanism, literature and identifier graph →
Reconstitution calculator (pre-filled for 5 mg)
HPLC and MS verified by UKAS-accredited laboratories.
Free on orders over £50. Next-day upgrade available.
COA and batch number on every vial.
Semaglutide 5mg — research reference material
n
Semaglutide 5mg is supplied by ADIPHEX as a research reference material in a 5mg presentation. Compound class: GLP-1 receptor agonist · 31-residue peptide, characterised in the literature as a incretin receptor agonist. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.
n
Research context
n
GLP-1 agonist; studied in glucose, appetite, metabolic research. Full mechanism detail, the identifier graph and selected peer-reviewed literature are set out on our Semaglutide research reference. Related compounds in the same research area: Tirzepatide, Retatrutide, Cagrilintide. You can also compare it side by side on our comparison tool.
n
Presentation
n
This listing is the 5mg presentation at >99% stated purity, catalogue reference SEM5.
n
Identifiers
n
- n
- CAS number: 910463-68-2
- Molecular formula: C187H291N45O59
- Molecular weight: 4113.58 g/mol
- Synonyms: Ozempic Active Compound, Wegovy Active Compound, NNC9204-0294, OG217SC
- Class: GLP-1 receptor agonist · 31-residue peptide
n
n
n
n
n
n
Format & quality
n
Supplied as 5mg at >99% purity. Identity and purity are characterised by reversed-phase HPLC and mass spectrometry, with a per-batch Certificate of Analysis available on request. This item is a lyophilised powder and requires reconstitution before use; bacteriostatic water is supplied separately, and our reconstitution guide covers volumes and concentrations. Solubility: H2O.
n
Storage
n
Store at -20°C, protected from light. Stated shelf life 3 years from date of manufacture. Always confirm against the Certificate of Analysis supplied with your batch.
n
Research use only — not for human or veterinary use, food, cosmetic or therapeutic application. ADIPHEX supplies this item as a laboratory reference material; no dosing or administration guidance is provided.
n
Frequently asked questions
n
What is Semaglutide 5mg?
n
GLP-1 receptor agonist · 31-residue peptide. GLP-1 agonist; studied in glucose, appetite, metabolic research. ADIPHEX supplies it as a research reference material only.
n
What is the CAS number for Semaglutide 5mg?
n
910463-68-2. Molecular formula C187H291N45O59. Molecular weight 4113.58 g/mol.
n
How should Semaglutide 5mg be stored?
n
At -20°C, protected from light, with a stated shelf life of 3 years. The batch Certificate of Analysis is the controlling document.
n
Certificate of Analysis
Reconstitution
For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.
Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.
-
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Nauck MA et al. · Molecular metabolism · 2021
PubMed PMID 33068776 -
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron.
Sloop KW et al. · Science translational medicine · 2024
PubMed PMID 39693407 -
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation.
Stefanakis K et al. · Metabolism: clinical and experimental · 2024
PubMed PMID 39481534
You may also need
Related compounds
